1.
|
Phase: Phase IV
Type: Treatment
Status: Active
Age: 50 and over
Sponsor: Other
Protocol IDs: SENORX-S07-002, NCT00699101
|
|
2.
|
Phase: Phase IV
Type: Treatment
Status: Active
Age: 50 and over
Sponsor: Other
Protocol IDs: S07-002, 1098558, NCT00882596
|
|
3.
|
Phase: Phase IV
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 1098987, NCT00882089
|
|
4.
|
Phase: Phase III
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: NSABP-B-39, RTOG-0413, SWOG-NSABP-B-39, NCT00103181
|
|
5.
|
Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: NSABP-B-43, NSABP-B-43, NCT00769379
|
|
6.
|
Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 21 and over
Sponsor: NCI
Protocol IDs: MDA-P50-CA-58183, H-19895, BCM-H-19895, BCM-P50-CA-58183, NCT00555152
|
|
7.
|
Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: Over 18
Sponsor: NCI
Protocol IDs: UPCC-15107, UPCC-15107, 807010, NCT00923143
|
|
8.
|
Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: IFHCC 09-002, NCT01023477
|
|
9.
|
Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: UMN-2002LS097, UMN-0211M35761, NCT00290654
|
|
10.
|
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: UCI 03-16, NCT00256217
|
|
11.
|
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: Not specified
Sponsor: NCI
Protocol IDs: UCSF-047522, UCSF-H8409-26206-01, MSKCC-06041, NCT00416403
|
|
12.
|
Phase: Phase II
Type: Diagnostic, Treatment
Status: Active
Age: 40 and over
Sponsor: Other
Protocol IDs: 1B-06-9, NCT00556907
|
|
13.
|
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: Over 21
Sponsor: NCI
Protocol IDs: OHSU-3872, 3872, OHSU-CTRC-1037, NCT00627276
|
|
14.
|
Phase: Phase II
Type: Treatment
Status: Active
Age: 30 and over
Sponsor: Other
Protocol IDs: 0601000957, NCT00611624
|
|
15.
|
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: SCCI 07-001.1, NCT00631852
|
|
16.
|
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: DCIS-WHM-703M, NCT00669747
|
|
17.
|
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: Over 21
Sponsor: NCI
Protocol IDs: OHSU-4702, eIRB 4702, OHSU-LAY-01, NCT00843167
|
|
18.
|
Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: CINJ-040807, 040807, NCT00909909
|
|
19.
|
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: NU-NWU07-9-02, NWU07-9-02, NCI-07-9-02, NCT00952731
|
|
20.
|
Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: J0822, NCT00982319
|
|
21.
|
Phase: Phase II
Type: Treatment
Status: Active
Age: 50 and over
Sponsor: NCI
Protocol IDs: CINJ-040902, 040902, S09-001, NCT01019720
|
|
22.
|
Phase: Phase I
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: JHOC-J0503, JHOC-05030803, NCT00290732
|
|
23.
|
Phase: Phase I
Type: Treatment
Status: Active
Age: Over 18
Sponsor: Other
Protocol IDs: 05-1053, NCT00325598
|
|
24.
|
Phase: Phase I
Type: Treatment
Status: Active
Age: 45 and over
Sponsor: NCI
Protocol IDs: CINJ-040801, 040801, CINJ-0220080173, NCT00749437
|
|
25.
|
Phase: Phase I
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: CASE-11107, CASE11107, CASE-11107-CC479, NCT00945061
|
